Resilience-building tool to help with advance care planning

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial at a cancer center will evaluate the feasibility, acceptability, and usability of the ROCKS web-based resilience intervention for both patients with advanced cancer and their family caregivers, compared with usual care. It will look at preliminary efficacy on completion of advance directives and explore how resilience influences self-efficacy, optimism, communication, coping, anxiety, and depression using a dyadic analysis. The study targets patients 18 or older with stage 3 or 4 cancer and a willing caregiver, all requiring basic English literacy and internet access. The primary focus is on advancing ACP engagement and resilience-linked outcomes in a dyadic patient–caregiver pair.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Eligible patients will (1) be ≥ 18 years of age; (2) be diagnosed with stage 3 or 4 cancer; and (3) have a family caregiver who is willing to participate.
* Eligible family caregivers will be ≥ 18 years of age. All participants must be able to read, write, and speak English with minimal assistance from others and have access to the internet on a smartphone, laptop, or computer.

Exclusion Criteria:

* Patient participants will be ineligible if they have (1) a Short Portable Mental Status Questionnaire (SPMSQ) score \< 8; or (2) have completed any form of advance directive.

Where it's running

• University of Illinois Chicago
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Li-Ting Longcoy
• Email: liting@uic.edu
• Phone: 312-996-3024

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Concise coaching to guide decisions for advanced cancer patients considering palliative procedures

  A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.

  Recruiting Singapore General Hospital · Singapore · NCT07789093

• Primary Palliative Care: A Feasibility Project for Family Health Units

  This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.

  Recruiting University of Coimbra · Coimbra and 1 other locations · NCT07737899

• Virtual Group Resilient Living for Advanced Cancer

  A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07659158

• IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy

  This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07648160

• Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain

  A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07636382

• UI-102 in advanced cancers (phase 1/2) first-in-human

  A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.

  Recruiting at 3 sites Phase 1/2 United Immunity, co., Ltd. · Dallas, Texas and 2 other locations · NCT07605962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.